Cytoplasmic-targeted parvalbumin blocks the proliferation of multipotent mesenchymal stromal cells in prophase

INTRODUCTION: Multipotent mesenchymal stromal cells (MSCs) have gained considerable interest because of their potential use in the treatment of a variety of diseases and injuries. Although remarkable advancements have been made in clinical studies, substantial concerns still regard the safety of MSC...

Descripción completa

Detalles Bibliográficos
Autores principales: Melo, Carolina Soares Barros, Arantes Faria, Jerusa Araújo Quintão, Corrêa, Natássia Caroline Resende, de Andrade, Carolina, Carvalho, Juliana Lott, Goes, Alfredo M, Rodrigues, Michele A, Gomes, Dawidson Assis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3854775/
https://www.ncbi.nlm.nih.gov/pubmed/23928293
http://dx.doi.org/10.1186/scrt291

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3854775/
https://www.ncbi.nlm.nih.gov/pubmed/23928293
http://dx.doi.org/10.1186/scrt291

Ejemplares similares